| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8242618 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Conclusion: The results of this analysis have demonstrated that dose escalation (>100 Gy) with GliaSite is well tolerated and associated with minimal toxicity. Local control improved with the use of GliaSite brachytherapy. The putative survival advantage seen in this study needs to be interpreted with caution; nevertheless, the data provide sufficient justification to investigate the potential role of radiation dose escalation in conjunction with GliaSite in the initial treatment of glioblastoma multiforme.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
James M.D., Abhay M.D., Arash J. M.D., Sylvan B. M.D., Robert M.D., Stuart M.D., Edmund M.D., Baldassarre M.D., Ph.D.,